Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine

被引:30
|
作者
Kaput, Jim
Perlina, Alla
Hatipoglu, Betul
Bartholomew, Amelia
Nikolsky, Yuri
机构
[1] Univ Illinois, Dept Surg, Chicago, IL 60612 USA
[2] European Nutrigenom Org, NuGO, Davis, CA 95616 USA
[3] Univ Calif Davis, NCMHD Ctr Excellence Nutr Genom, Davis, CA 95616 USA
[4] GeneGO, Encinitas, CA 92024 USA
[5] Univ Illinois, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60612 USA
关键词
15-dOH-prostaglandin J(2); dietary lipids; nutrigenomics; pharmacogenomics; rosiglitazone; Type; 2; diabetes;
D O I
10.2217/14622416.8.4.369
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The maintenance of health and the prevention and treatment of chronic diseases are influenced by naturally occurring chemicals in foods. in addition to supplying the substrates for producing energy, a large number of dietary chemicals are bioactive -that is, they alter the regulation of biological processes and, either directly or indirectly, the expression of genetic information. Nutrients and bioactives may produce different physiological phenotypes among individuals because of genetic variability and not only alter health, but also disease initiation, progression and severity. The study and application of gene-nutrient interactions is called nutritional genomics or nutrigenomics. Nutrigenomic concepts, research strategies and clinical implementation are similar to and overlap those of pharmacogenomics, and both are fundamental to the treatment of disease and maintenance of optimal health.
引用
收藏
页码:369 / 390
页数:22
相关论文
共 50 条
  • [21] Clinical Application of Nutrigenomics
    Kwak, Mi Sun
    Hahm, Ki Baik
    Joung, H. J.
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2006, 49 (02): : 163 - 172
  • [22] Catalyzing clinical implementation of pharmacogenomics and personalized medicine interventions in Africa
    Mathuba, Bathusi
    Koromina, Maria
    Mitropoulou, Christina
    Patrinos, George P.
    PHARMACOGENOMICS, 2021, 22 (02) : 115 - 122
  • [23] Pharmacogenomics - a minor rather than major force in clinical medicine
    Polasek, Thomas M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (03) : 203 - 212
  • [24] Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions
    Klein, Michelle E.
    Parvez, Md Masud
    Shin, Jae-Gook
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2368 - 2379
  • [25] Pharmacogenomics in cardiovascular medicine
    Carlquist, JF
    Anderson, JL
    DRUG DEVELOPMENT RESEARCH, 2004, 62 (03) : 180 - 190
  • [26] Pharmacogenomics and Personalized Medicine
    Cecchin, Erika
    Stocco, Gabriele
    GENES, 2020, 11 (06) : 1 - 5
  • [27] Artificial Intelligence, Healthcare, Clinical Genomics, and Pharmacogenomics Approaches in Precision Medicine
    Abdelhalim, Habiba
    Berber, Asude
    Lodi, Mudassir
    Jain, Rihi
    Nair, Achuth
    Pappu, Anirudh
    Patel, Kush
    Venkat, Vignesh
    Venkatesan, Cynthia
    Wable, Raghu
    Dinatale, Matthew
    Fu, Allyson
    Iyer, Vikram
    Kalove, Ishan
    Kleyman, Marc
    Koutsoutis, Joseph
    Menna, David
    Paliwal, Mayank
    Patel, Nishi
    Patel, Thirth
    Rafique, Zara
    Samadi, Rothela
    Varadhan, Roshan
    Bolla, Shreyas
    Vadapalli, Sreya
    Ahmed, Zeeshan
    FRONTIERS IN GENETICS, 2022, 13
  • [28] Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
    Avery, Peter
    Mousa, Shaymaa S.
    Mousa, Shaker A.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2009, 2 : 79 - 91
  • [29] Some applications of pharmacogenomics and epigenetics in drug development and use in pursuit of personalized medicine
    M. C. Powanda
    E. D. Moyer
    Inflammopharmacology, 2012, 20 (5) : 245 - 250
  • [30] Research in nutrigenomics and potential applications to practice
    Ferguson, Lynnette R.
    Barnett, Matthew P. G.
    NUTRITION & DIETETICS, 2012, 69 (03) : 198 - 202